Dermatology: Acne, Eczema, Psoriasis & Rosacea • ICD-10-CM L92.9
Granuloma - injection
Also known as: Injected, Injection, Injecting, Injections
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM L92.9 • 6 Linked .gov / PubMed Citations
•
Governance: Dr. Priya Nair, MD, FAAD (NPI #1295730425)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Granuloma - injection Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: For patients presenting with Granuloma - injection (also termed Injected or Injection) (ICD-10-CM L92.9), Dermatology: Acne, Eczema, Psoriasis & Rosacea protocols prioritize or targeted biologics [Granuloma - injection L92.9] paired with baseline and interval Affected Body Surface in Granuloma - injection (L92.9: Area (BSA /) assessment.
- 2 Real-world patient consensus: Synonyms for Granuloma - injection (L92.9): Injected, Injection, Injecting (Skin & Dermatology).
- 3 Typical cash cost range: Workup highlights for Granuloma - injection (L92.9): or targeted biologics [Granuloma - injection L92.9].
- 4 Top reported side effects / signs: Follow-up benchmark in Granuloma - injection: maintaining Affected Body Surface in Granuloma - injection (L92.9: Area (BSA /) within Clear or Almost Clear (IGA 0–1) (L92.9).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Granuloma - injection
What Is Granuloma - injection?
For patients presenting with Granuloma - injection (also termed Injected or Injection) (ICD-10-CM L92.9), Dermatology: Acne, Eczema, Psoriasis & Rosacea protocols prioritize or targeted biologics [Granuloma - injection L92.9] paired with baseline and interval Affected Body Surface in Granuloma - injection (L92.9: Area (BSA /) assessment.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Granuloma - injection (code L92.9) is epidermal barrier filaggrin/ceramide in Granuloma - injection (L92.9: disruption), which Dermatology: Acne, Eczema, Psoriasis & Rosacea clinicians address while surveilling Affected Body Surface in Granuloma - injection (L92.9: Area (BSA /) (Clear or Almost Clear (IGA 0–1) (L92.9)).
Common Symptoms & Clinical Signs
- • Presentation of Granuloma - injection (L92.9): persistent erythematous plaques, in Granuloma - injection (L92.9: scaly patches, pruritic)
- • Secondary Granuloma - injection clinical sign: compromised epidermal barrier in Granuloma - injection (L92.9: with dryness, fissuring,)
- • Symptom flares in Granuloma - injection correlating with Affected Body Surface in Granuloma - injection (L92.9: Area (BSA /) deviation outside Clear or Almost Clear (IGA 0–1) (L92.9)
- • Functional skin & dermatology impact requiring or targeted biologics [Granuloma - injection L92.9] evaluation (L92.9)
Granuloma - injection Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | L92.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Dermatology: Acne, Eczema, Psoriasis & Rosacea | NLM Clinical Tables |
| Diagnostic / Lab Marker: Affected Body Surface in Granuloma - injection (L92.9: Area (BSA /) | Clear or Almost Clear (IGA 0–1) (L92.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fasting Lipids & in Granuloma - injection (L92.9: ALT (if systemic) | Within baseline reference limits (L92.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D in Granuloma - injection (L92.9: & hs-CRP) | 25(OH)D 40–65 ng/mL (L92.9) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Granuloma - injection
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Technetium Tc 99m Medronate Technetium Tc 99m Medronate Generic • RxCUI RXN-65857505-1749 | Radioactive Diagnostic Agent | 82% | $1.0500 | $ 51.03 /mo |
| Nivolumab Opdivo • RxCUI RXN-00033756-2313 | Programmed Death Receptor-1 Blocking Antibody | 78% | $1.5200 | $ 70.06 /mo |
| Thiamine Hydrochloride Thiamine Hydrochloride Generic • RxCUI 313324 | FDA Prescription Therapeutic Agent | 83% | $2.1256 | $ 94.59 /mo |
| Marcaine, Lidocaine, Povidone Iodine Marcaine, Lidocaine, Povidone Iodine Generic • RxCUI 1724880 | FDA Prescription Therapeutic Agent | 92% | $2.7100 | $ 118.26 /mo |
| Gadoterate Meglumine Dotarem, Clariscan • RxCUI RXN-70436123-1767 | Gadolinium-based Contrast Agent | 93% | $0.8000 | $ 40.90 /mo |
| Hydroxyzine Atarax • RxCUI RXN-04049878-1903 | Antihistamine | 82% | $0.1326 | $ 5.59 /mo |
| Colistimethate Sodium Colistimethate Sodium Generic • RxCUI 1117522 | Polymyxin-class Antibacterial | 84% | $15.4867 | $ 185.00 /mo |
| Busulfan Myleran • RxCUI 253113 | Alkylating Drug | 83% | $0.3900 | $ 24.30 /mo |
| Ketamine Hydrochloride Ketalar • RxCUI 206967 | General Anesthetic | 91% | $0.6682 | $ 35.56 /mo |
| Lanreotide Acetate Somatuline Depot • RxCUI 749811 | Somatostatin Analog | 90% | $2.7000 | $ 117.85 /mo |
| Exenatide Byetta • RxCUI 847910 | GLP-1 Receptor Agonist | 83% | $276.0163 | $ 624.50 /mo |
| Octreotide Acetate Sandostatin, Sandostatin Lar Depot • RxCUI 1090558 | Somatostatin Analog | 86% | $5.2400 | $ 185.00 /mo |
| Zinc Chloride Zinc Chloride Generic • RxCUI 237508 | Copper Absorption Inhibitor | 74% | $0.0158 | $ 9.14 /mo |
| Indocyanine Green Ic-Green, Zyogreen • RxCUI RXN-707102018-1793 | Diagnostic Dye | 89% | $2.3700 | $ 104.49 /mo |
| Dacarbazine Dacarbazine Generic • RxCUI 1731338 | Alkylating Drug | 88% | $2.5400 | $ 111.37 /mo |
| Sodium Iothalamate I-125 Injection Glofil-125 • RxCUI RXN-509147729-2357 | Radioactive Diagnostic Agent | 91% | $2.2100 | $ 98.00 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Granuloma - injection)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Ivarmacitinib provides rapid and continuous improvement in patients with Ivarmacitinib provides rapid and continuous improvement across all anatomical regions in patients with moderate-to-severe AD. Inflammopharmacology • 2026-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41396379 ↗ |
| Can This Approach Help? Inside the Latest Research on Maintained improvement of outcomes related to skin clearance, itch, sleep and AD symptom improvement was maintained up to Week 200 with baricitinib 4 mg. The Journal of dermatological treatment • 2025-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41306112 ↗ |
| New Insights on Identifying Symptom Clusters for Acute Dermatitis-Exploratory Analysis of a: What a 376-Participant Study Found Symptom clusters should be managed together to optimize improvement in patients. Clinical breast cancer • 2026-06-15 • Phase III Randomized Trial | N = 376 | 87/100 | PMID 42066679 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients Targeting the interleukin-5 receptor with benralizumab or circulating interleukin-5 with mepolizumab are effective OGC-sparing strategies in patients with EGPA. Arthritis & rheumatology (Hoboken, N.J.) • 2026-03-15 • Phase III Randomized Trial | N = 70 | 82/100 | PMID 40977418 ↗ |
Zero-PHI Patient Support & Cohort Discussions
Granuloma - injection Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Granuloma - injection community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Granuloma - injection.